Justicidone, a C-5, C-8 dioxo-lignan of the arylnaphthalene type isolated from Justicia hyssopifolia, and its synthetic precursors were tested for the activity against Leishmania braziliensis and Leishmania amazonensis promastigotes in vitro. Justicidone showed activity against L. braziliensis with an IC 50 of 181.90 μM, while, the diasteromeric mixture of one of its synthetic precursors exhibited activity against both parasite strains with an IC 50 of 99.27 μM (L. braziliensis) and 181.75 μM (L. amazonensis). This activity has not previously been reported for dibenzylbutyrolactones and dioxo-lignans.
Leishmaniasis is a severe infectious disease which has diverse clinical manifestations and affects about 12 million people. This disease is caused by the intracellular form (amastigote) of parasitic protozoa of the genus Leishmania and is spread by the bite of sandflies of the subfamily phlebotominae, which are infected with Leishmania parasites. According to the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR) the illness affects 88 countries mainly in the tropical or sub-tropical regions of the world.
One of the most common forms of this disease is cutaneous leishmaniasis causing skin ulcers. It is much more frequent (more than 90% of new cases) in Iran, Afghanistan, Syria, Saudi Arabia, Brazil and Peru. The most severe and deadly form of this disease is visceral leishmaniasis caused by Leishmania donovani in the Old World and L. infantum in both the Old and the New World. This form affects several internal organs such as spleen, liver, and bone marrow and it may be fatal if untreated [1] . It is highly disseminated in Bangladesh, Brazil, India and the Sudan and has been identified as an opportunistic disease in immnunocompromised patients, especially those infected with HIV [2] .
The pentavalent antimonial drugs, sodium stibogluconate and meglumine antimoniate represent the main line in chemoterapy. The platinum complex salt pentamidine is used when antimonials are ineffective, but its usefulness is limited by its toxicity. Several antibiotics have been used against Leishmania in clinical trials with uneven results; for example, the aminoglycoside antibiotic paromomycin, or the polyene amphotericin B has been used successfully in the treatment of visceral leishmaniasis, [3] but they have the disadvantage of requiring parenteral administration [4] . Since the biosynthesis of sterols in Leishmania and fungi are similar, the azoles, known as antifungal drugs, have been tested against the parasite. For instance, ketoconazol has activity in vivo against L. mexicana [5] . Nevertheless, the chemotherapy available up to now is far from satisfactory due to the toxicity and the difficulties in drug administration.
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On the other hand, the demands for new antileishmanial drugs have increased in recent years due to the appearance of strains resistant to the pentavalent antimonial drugs [4, 6] .
In the search of new effective drugs against leishmaniasis, several natural products and their derivatives have proven to have this activity. Aphidicolin, isolated from Nigrospora sphaerica, and derivatives [7] are active against leishmaniasis. Compounds isolated from plants, such as dihydrochalcones from Piper elongatum [8] and the flavonoids luteolin and quercetin [9] have proved to be antileishmanial agents.
Lignans are widely distributed within the vegetable kingdom and show important pharmacological activities [10] . Tetrahydrofuranic lignans obtained from the inflorescence of Piper solmsianum exhibit activity in vitro against the trypomastigote form of Trypanosoma cruzi, the etiologic agent of Chagas disease [11] . Antileishmanial activity in neolignans has also been reported. Such is the case of nyasol, isolated from Asparagus africanus [12] and for neolignans isolated from the Virola genus and their synthetic analogs [13] . Furofuranic lignans (+)-medioresinol and (-)-lirioresinol B, isolated from Doliocarpus dentatus (Dillenicaceae), have also shown such activity [14] .
Quinones constitute an important class of natural compounds isolated from plants, fungi and bacteria [15] and exhibit antitumor, antibacterial, antimalarial and antifungal activities [16] . We have previously reported on the isolation, structure determination [17] and total synthesis of justicidone [18] , a C-5, C-8 dioxo-lignan of the arylnaphthalene type (Compound 1, Scheme 1). This compound, its synthetic precursors and structurally related sesamin and justicidin E (Scheme 1) were tested for activity against Leishmania braziliensis and Leishmania amazonensis promastigotes in vitro. Justicidin E and sesamin were isolated from Justicia hyssopifolia [19] , whereas compound 9, justicidone and its precursors were synthesised in our laboratory. Natural lignans justicidin E (11) and sesamin (12) were not active at 862 μM and 870 μM respectively, whereas justicidone exhibited leishmanicidal activity against Leishmania braziliensis with an IC 50 of 181.90 μM. On the other hand, a diasteromeric mixture of compound 4 showed IC 50 values of 99.27 μM and 181.75 μM against L. brazilensis and L. amazonensis, respectively (Tables 1 and 2 ). This is a moderate activity compared with the IC 50 of 65.8 μM against L. braziliensis for ketoconazol used as a control. The anti-leishmanial activity of dibenzylbutyrolactones and dioxo-lignans have not been reported previously. Anti-leishmanial activity of justicidone and its synthetic precursors
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The IC 50 for compounds 5, 7 and 8 gave values between 290 and 384 μM while the activities for compounds 2, 3, 6, 9 and 10 were minimal at concentrations higher than 500 μM. Among the tested compounds, the synthetic precursor of justicidone, 4 in Scheme 1, was the most active. The presence in this lignan of a 1,3-dithiane that provides two sulphur bridges seems to support the conclusions of Barata et al. about the anti-leishmanial properties of certain neolignans isolated from the genus Virola and their derivatives [13] . In this study the greatest activity was found in neolignan derivatives with a sulphur bond, an important structural feature to be considered in the search of effective new anti-leishmanial drugs. Nevertheless, compounds 2 and 3, which also have the 1,3-dithiane structure, are inactive.
Experimental
Leishmanicidal activity was determined using the 
